This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Walgreens Boots Alliance (WBA) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Walgreens Boots Alliance (WBA) closed the most recent trading day at $34.23, moving -1.55% from the previous trading session.
Walgreens Boots Alliance (WBA) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Walgreens Boots Alliance (WBA) closed at $36.24 in the latest trading session, marking a +0.78% move from the prior day.
Walgreens Boots Alliance (WBA) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the latest trading session, Walgreens Boots Alliance (WBA) closed at $35.32, marking a +0.14% move from the previous day.
Walgreens Boots Alliance, Inc. (WBA) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
Walgreens (WBA) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Walgreens Boots Alliance (WBA) Stock Moves -0.34%: What You Should Know
by Zacks Equity Research
Walgreens Boots Alliance (WBA) closed at $35.06 in the latest trading session, marking a -0.34% move from the prior day.
Walgreens Boots Alliance (WBA) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Walgreens Boots Alliance (WBA) closed the most recent trading day at $36.80, moving +0.08% from the previous trading session.
Walgreens Boots Alliance, Inc. (WBA) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
Walgreens (WBA) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Walgreens Boots Alliance (WBA) Stock Moves -0.05%: What You Should Know
by Zacks Equity Research
In the latest trading session, Walgreens Boots Alliance (WBA) closed at $38.22, marking a -0.05% move from the previous day.
Investors Heavily Search Walgreens Boots Alliance, Inc. (WBA): Here is What You Need to Know
by Zacks Equity Research
Walgreens (WBA) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Here is What to Know Beyond Why Walgreens Boots Alliance, Inc. (WBA) is a Trending Stock
by Zacks Equity Research
Walgreens (WBA) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
NCR Stock Rallies 13% on Veritas Capital Takeover Report
by Zacks Equity Research
If Veritas Capital succeeds in concluding a takeover deal for NCR, it is likely to be one of the biggest leveraged buyouts in recent history.
Zacks Industry Outlook Highlights CVS Health, Walgreens Boots Alliance and Amazon
by Zacks Equity Research
CVS Health, Walgreens Boots Alliance and Amazon have been highlighted in this Industry Outlook article.
2 Retail Pharmacy and Drugstore Stocks to Watch Amid Industry Challenges
by Urmimala Biswas
The Zacks Retail Pharmacy and Drugstore industry is gaining from the growing demand for digital healthcare support. Industry players like CVS and WBA are likely to gain the most. However, reimbursement challenges are hurting the overall industry health.
Is Trending Stock Walgreens Boots Alliance, Inc. (WBA) a Buy Now?
by Zacks Equity Research
Recently, Zacks.com users have been paying close attention to Walgreens (WBA). This makes it worthwhile to examine what the stock has in store.
Here's Why You Should Retain Walgreens Boots (WBA) For Now
by Zacks Equity Research
Investors are optimistic about Walgreens Boots (WBA), given its better-than-expected earnings and strategic alliances.
Is Most-Watched Stock Walgreens Boots Alliance, Inc. (WBA) Worth Betting on Now?
by Zacks Equity Research
Zacks.com users have recently been watching Walgreens (WBA) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Company News for Jul 1, 2022
by Zacks Equity Research
Companies in The News Are: WBA,LNN,NG,RH
Worst 1H Since 1970 Ends Trading Day in the Red
by Mark Vickery
It's been the worst first half of a year for equity markets in more than half a century. So why should the final trading day of it be anything but down?
Walgreens Boots (WBA) Q3 Earnings Top Estimates, Revenues Miss
by Zacks Equity Research
Walgreens Boots (WBA) reports better-than-expected Q3 earnings, with robust sales contributions from the International and Walgreens Health segments.
Walgreens Boots Alliance (WBA) Beats Q3 Earnings Estimates
by Zacks Equity Research
Walgreens (WBA) delivered earnings and revenue surprises of 1.05% and 0.43%, respectively, for the quarter ended May 2022. Do the numbers hold clues to what lies ahead for the stock?
Company News for Jun 28, 2022
by Zacks Equity Research
Companies in The News Are: BNTX,PFE,WBA,HOOD,SAVE,ULCC,JBLU
Walgreens (WBA) to Report Q3 Earnings: What's in the Cards?
by Zacks Equity Research
Robust performances across the U.S. pharmacy and retail business are likely to have contributed to Walgreens' (WBA) Q3 performance.
Walgreens Boots Alliance (WBA) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Walgreens Boots Alliance (WBA) closed at $40.89 in the latest trading session, marking a +1.09% move from the prior day.
Analysts Estimate Walgreens Boots Alliance (WBA) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Walgreens (WBA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Rite Aid (RAD) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Rite Aid (RAD) delivered earnings and revenue surprises of 14.29% and 5%, respectively, for the quarter ended May 2022. Do the numbers hold clues to what lies ahead for the stock?